UK-based QinetiQ Group has received approval from the Foreign Investment Policy Division to acquire 45.92 million shares in pSivida as consideration for its 41.3% shareholding in UK operating subsidiary pSiMedica Ltd.
Subscribe today for award-winning, unbiased and trusted journalism